FindTrial
Sign In

Alpha-tocopherol to reduced colistin nephrotoxicity in hospitalized patient(BAH)pilot study RCT

Alpha-tocopherol to reduced colistin nephrotoxicity in hospitalized patient

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190730001
Enrollment
40
Registered
2019-07-30
Start date
2019-07-29
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Follow up AKI by cr and serum NGAL Vitamin E Colistin AKI

Interventions

Start vitamin E prompt colistin above 7day,Start colistin and follow up cr
Experimental Drug,Experimental Drug
Colistin and vitaminE,Start colistin without vitaminE

Sponsors

VitaminE
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age over 18 year Inpatients BAH receive colistin

Exclusion criteria

Exclusion criteria: AKI Bleeding tendency

Design outcomes

Primary

MeasureTime frame
Aki from colistin After 7day expose colistin Rate—

Secondary

MeasureTime frame
Stage of aki 7day after start colistin rate—

Countries

Thai

Contacts

Public ContactNuttapol pattamin

Thailand

Iamnutmd@hotmail.com025347555

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026